Since the introduction of vitamin K antagonists in the 1950s, the field of anticoagulation has evolved considerably to include an ever-increasing number of new therapeutic agents and procedures for thromboembolic disease. The rapidity of change presents a challenge for busy healthcare providers to stay abreast of the latest developments in the management of thrombotic disease. This book outlines the current state of antithrombotic therapy which will serve as a foundation upon which the field will inevitably continue to grow and develop. We hope that the readers will find this book to be a valuable resource and reliable reference for patient care.
Joe F. Lau, MD, PhD
Manhasset, NY, USA
Geoffrey D. Barnes, MD, MSc
Ann Arbor, MI, USA
Michael B. Streiff, MD
Baltimore, MD, USA